- Home
- RCUS vs CDP Comparison
RCUS vs CDP Comparison
Compare RCUS & CDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCUS | CDP |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.1B |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | RCUS | CDP |
|---|---|---|
| Price | $27.42 | $37.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 7 |
| Target Price | $31.90 | ★ $34.57 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 4.14% |
| EPS Growth | N/A | ★ 8.94 |
| EPS | N/A | ★ 0.34 |
| Revenue | $247,000,000.00 | ★ $763,923,000.00 |
| Revenue This Year | N/A | $1.18 |
| Revenue Next Year | $45.62 | $3.71 |
| P/E Ratio | ★ N/A | $110.68 |
| Revenue Growth | N/A | ★ 1.41 |
| 52 Week Low | $8.84 | $26.91 |
| 52 Week High | $31.74 | $38.06 |
Technical Indicators
Market Signals| Indicator | RCUS | CDP |
|---|---|---|
| Relative Strength Index (RSI) | 48.46 | 70.12 |
| Support Level | $20.20 | $30.86 |
| Resistance Level | $28.72 | $38.06 |
| Average True Range (ATR) | 1.37 | 0.65 |
| MACD | -0.48 | -0.03 |
| Stochastic Oscillator | 28.74 | 78.60 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About CDP COPT Defense Properties of Beneficial Interest
COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. The company has two reportable segments: Defense/IT Portfolio; and Other. Defense/IT Portfolio includes sub-segments such as: Fort George G. Meade and the Baltimore/Washington Corridor (Fort Meade/BW Corridor); Redstone Arsenal in Huntsville, Alabama; Northern Virginia Defense/IT Locations (NoVA Defense/IT); Lackland Air Force Base in San Antonio, Texas; locations serving the U.S. Navy (Navy Support); and data center shells in Northern Virginia.